NCT06059833

Serum Magnesium Level in Type 2 Diabetes Mellitus

Sohag University·ClinicalTrials.gov·diagnostic testNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Diabetes Mellitus
Drug/Device/Intervention
Magnesium
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Sohag University
Location
Sohag, Egypt
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2023
End date
Sep 01, 2024
Enrollment
120 participants
Primary outcome

magnesium perecentage

Summary

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent
 hyperglycemia. It may be due to impaired insulin secretion, resistance to peripheral actions
 of insulin, or both . Chronic hyperglycemia in synergy with the other metabolic aberrations
 in patients with diabetes mellitus can cause damage to various organ systems, leading to the
 development of disabling and life-threatening health complications, most prominent of which
 are microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular complications
 leading to a 2-fold to 4-fold increased risk of cardiovascular diseases Mg2+ deficiency is
 usually identified by the measurement of serum Mg2+ concentration. Hypomagnesemia is defined
 by a serum Mg2+ concentration 0.75 mmol/L, but a deficiency due to low dietary intake in
 otherwise healthy people is uncommon. Although overt signs of clinical Mg2+ deficiency are
 not routinely recognized in the healthy population, relatively low Mg2+ intake and/or Mg2+
 status have been shown to be associated with chronic diseases, including cardiovascular
 disease, T2DM, osteoporosis, pulmonary disease, depression, migraine headaches, inflammation,
 and cancer

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06059833
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06059833 through Pure Global AI's free database. This phase not specified trial is sponsored by Sohag University and is currently Not yet recruiting. The study focuses on Diabetes Mellitus. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.